World of DTC Marketing
JULY 21, 2021
SUMMARY: DTC marketing is not the reason why prescription drugs cost so much. Here are some myths around DTC marketing: 1ne: DTC ads result in patients asking for prescriptions they don’t need. 2wo: DTC marketing is one of the reasons prescription drugs cost so much. DTC ads raise awareness around health conditions.
World of DTC Marketing
APRIL 12, 2021
We need a 21st-century approach that puts patient safety first. In other words, money over safety. Ironically, in later times, the intense competition for out-of-patent drugs has subsided, which has led to spiraling rises in generic drug prices and shortages. Up to 90% of drugs now sold in the US and UK are generic.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
NOVEMBER 16, 2022
Novartis completed the spin-out of Alcon in 2019, separating products like contact lenses and over-the-counter eyedrops from its prescription eye medicines, headed by age-related macular degeneration (AMD) blockbuster Lucentis (ranibizumab), which is partnered with Roche. billion in the first nine months of this year.
PM360
NOVEMBER 29, 2022
When developing content for new drug labels, life sciences companies’ regulatory teams face challenges in gathering intelligence to better understand competitive factors, market dynamics, and effective approval strategies. Understanding patient sub-group exceptions for competitive or for label development purposes.
Pharmaceutical Technology
DECEMBER 22, 2022
Theft, fraudulent prescriptions and unsanctioned distribution by patients and medical practitioners are the most common ways in which legal fentanyl products are illegally secured. Increased trafficking of illegal fentanyl represents a new threat to public health and safety. A lethal drug that creates its own demand.
European Pharmaceutical Review
NOVEMBER 8, 2022
In the current US Congressional session, Congress has focused heavily on legislation directed at reducing prescription drug prices. The new law will also require drug manufacturers to pay rebates to Medicare if they increase drug prices faster than consumer inflation.
Clarivate
OCTOBER 25, 2023
While more expensive than type 2 diabetes drugs, blood thinners follow a similar pattern of high prescription volumes. In both cases, a shift in formulary placement could lower prescription volumes and reduce member utilization. exclusions exist for orphan drug designation and biosimilar competition ). With 27.5%
Expert insights. Personalized for you.
285 
Let's personalize your content